Wegovy Price UK 2026: How Much Does Each Dose Cost and Is It Worth It?

Wegovy (semaglutide) costs between £130 and £295 per pen in the UK private market in 2026, depending on the dose strength and the pharmacy provider. The 0.25 mg starter dose begins at around £130 per pen from some GPhC registered pharmacies, while the 2.4 mg maintenance dose reaches up to £295 across the market.

Like all GLP 1 treatments, Wegovy follows a step up titration schedule, meaning the dose, and therefore the cost, increases every four weeks. Most people will not be paying the starter price beyond the first month. Therefore, planning for the full cost curve is more useful than focusing on the headline figure alone.

This article is fully independent. No pharmacy or provider is promoted here, and nothing in this piece constitutes medical advice. Wegovy is a prescription only medicine in the UK.

Wegovy is the brand name for semaglutide 2.4 mg, a GLP 1 receptor agonist manufactured by Novo Nordisk. It works by mimicking the GLP 1 hormone naturally produced in the gut, which regulates appetite, slows gastric emptying, and influences satiety signals in the brain.

The reason Wegovy uses a titration schedule is tolerability. Starting at the full 2.4 mg dose would cause significant gastrointestinal side effects in most people. Instead, patients begin at 0.25 mg and increase gradually, giving the body time to adjust before each dose step.

If you want clinical context before comparing prices, the Wegovy semaglutide injection UK guide explains how semaglutide works, its trial background, and who it is typically prescribed for.

The table below reflects approximate pricing across GPhC registered UK pharmacies as of 2026. Prices vary between providers and are subject to change, so always confirm directly with the pharmacy before ordering.

Each Wegovy pen contains four pre filled doses, making the per pen cost equivalent to one month of medication at each dose step.

For a live, regularly updated comparison across verified providers for all dose strengths, the Wegovy price comparison across UK weight loss treatments helps you compare semaglutide costs alongside Mounjaro and Saxenda.

The standard Wegovy titration schedule runs across five dose steps over approximately 17 weeks before reaching the maintenance dose:

• Month 1, weeks 1 to 4: 0.25 mg with an estimated cost of £130 to £170
• Month 2, weeks 5 to 8: 0.5 mg with an estimated cost of £145 to £185
• Month 3, weeks 9 to 12: 1 mg with an estimated cost of £175 to £220
• Month 4, weeks 13 to 16: 1.7 mg with an estimated cost of £215 to £270
• Month 5 and beyond, week 17 onwards: 2.4 mg with an estimated cost of £240 to £295 per month

Some patients stabilise at 1 mg or 1.7 mg rather than progressing to the full 2.4 mg dose. In those cases, the ongoing monthly cost is correspondingly lower. However, this is a clinical decision based on individual response and tolerability, not a financial one to make independently.

The key implication for budgeting is that the advertised from £130 per month figure applies to the first four weeks only. By month five, most patients on the standard schedule will be paying between £240 and £295 per month for the medication alone.

Estimated Year One Cost Including Titration Phase

These estimates include the lower costs of the titration phase in months one through four, then project ongoing costs at the maintenance dose.

Estimated Ongoing Annual Cost at Maintenance

All figures are estimates and do not include consultation fees, delivery charges, or programme costs where applicable.

The medication pen is the primary cost, but several additional fees frequently apply depending on the provider:

Consultation and prescription fees. Some providers include initial and renewal consultations in the medication price. Others charge £20 to £50 per clinical episode separately. Over a year, this can add £100 to £300 or more to total costs.

Delivery charges. Wegovy requires cold chain handling and refrigerated delivery. Delivery fees vary from zero to approximately £15 per order. On a monthly ordering cycle, this adds up noticeably across a year.

Monitoring or programme fees. Certain providers bundle structured coaching, progress tracking, or clinical check in programmes into the service, charging these as a subscription layer on top of the medication cost.

Dose step price increases. As detailed in the titration table above, each dose step carries a higher pen price. Budgeting only for the starter price will underestimate true costs considerably.

Therefore, the most accurate comparison between providers involves totalling all fee components, not just the pen price. The best weight loss treatment options comparison for all in UK pharmacy pricing aggregates verified data across more than 60 GPhC registered pharmacies, making it easier to conduct a genuine like for like comparison without visiting dozens of individual pharmacy sites.

Price comparison between Wegovy and Mounjaro is one of the most common questions people have when researching GLP 1 treatments. Here is how the two sit side by side across their dose ranges:

At the starter dose, the two treatments are broadly comparable in price. However, the gap widens at higher doses, and Mounjaro at its maximum 15 mg dose tends to be the more expensive option across most providers.

Whether that price difference is meaningful depends on individual clinical response, a factor that cannot be determined from price data alone. For a full three way comparison including Saxenda, see the Mounjaro vs Wegovy vs Saxenda comparison for UK treatment prices.

Yes, but access is currently limited. Wegovy received NICE approval for use in weight management in England in 2023, and NHS commissioning has begun through specialist weight management services. However, eligibility is subject to specific clinical criteria, and the rollout is phased rather than universal.

In practice, most people in the UK still access Wegovy through private prescriptions in 2026, either because they do not meet NHS eligibility criteria or because NHS waiting times and regional availability make private access the more realistic route.

This article covers only private market pricing. For NHS eligibility information, speaking with a GP or specialist weight management service is the appropriate route.

Saxenda (liraglutide) is the third main injectable weight loss option in the UK private market. Unlike Wegovy and Mounjaro, which are weekly injections, Saxenda is injected daily, which changes how pricing is structured.

Approximate monthly costs for Saxenda across the titration range run from around £150 to £290. At some dose levels and with some providers, this sits slightly below Wegovy pricing. However, the daily injection frequency and generally lower average clinical weight loss benchmarks compared to Wegovy are factors that affect the overall value equation.

For an independent overview of how Saxenda compares on mechanism and evidence, see the Saxenda liraglutide treatment guide for UK patients.

Because Wegovy is a prescription only medicine, purchasing it without a proper clinical assessment is both illegal and clinically unsafe. Before ordering from any online pharmacy, confirm the following:

1. GPhC registration: verify the pharmacy registration number on the official GPhC pharmacy register.
2. MHRA internet pharmacy logo: it should be displayed and clickable on the pharmacy homepage.
3. Named GMC registered prescriber: the clinician issuing the prescription should be identifiable and verifiable.
4. Full fee transparency before checkout: all costs including consultation, delivery, and monitoring fees should be disclosed before payment.
5. Verified independent reviews: check Trustpilot ratings rather than curated testimonials on the pharmacy website.

For a structured guide to evaluating pharmacy credentials alongside pricing, the UK online pharmacy verification and GPhC safety standards guide is a useful independent reference point.

Wegovy (semaglutide) costs between £130 and £295 per pen in the UK private market in 2026, with prices rising at each step of the dose titration schedule. At the 0.25 mg starter dose, most patients pay £130 to £170. By the 2.4 mg maintenance dose, the monthly cost rises to £240 to £295, not including any additional consultation, delivery, or programme fees.

Annual costs at maintenance range from approximately £2,880 to £3,540 for patients who progress to the full 2.4 mg dose, with lower figures for those who stabilise at 1 mg or 1.7 mg.

To compare Wegovy pricing against Mounjaro and Saxenda across all dose steps and providers, visit the Mounjaro vs Wegovy vs Saxenda comparison at Healthwise360. For the full cross provider price breakdown, the weight loss treatment price comparison guide covers all three treatments in detail.

This article is for informational purposes only and does not constitute medical advice. Wegovy is a prescription only medicine in the UK. All prices are approximate and subject to change. Always confirm directly with a GPhC registered pharmacy before purchasing.

Suggested hashtags: #WegovyPriceUK #SemaglutidePrice #WegovyCost #WeightLossTreatmentUK #GLP1UK #WegovyVsMounjaro